Dyne Therapeutics, Inc.
USD22.42
+1.16 (+5.44%)
CEO
John G. Cox
IPO Date
2020-09-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$21.28
Prev. Close
$21.26
Day Low
$21.18
Day High
$22.49
52W Low
$8.06
52W High
$25.00
Market Cap
$3.71B
Volume
0.47M
| -7.0 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -258.4% | -142.9% | 0.30 | 2.53 | -3.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -66.6% | -54.9% | 0.12 | 9.46 | -3.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -40.5% | -35.1% | 0.09 | 13.31 | -4.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -17.2% | -16.6% | 0.00 | 31.83 | -16.9 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -96.4% | -82.4% | 0.00 | 6.26 | -80.2 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 98.6% | -58.2% | -0.69 | 11.47 | -51.3 |
| 31 Dec 2017 | FY | -479.4% | 15.0% | 4.0% | 0.6% | 4.44 | 1.45 | 50.9 |
| 31 Dec 2016 | FY | -67.0% | -90.8% | -60.7% | -9.5% | 4.40 | 3.26 | -2.5 |
| -5.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -15.6% | -12.5% | 0.17 | 13.47 | -4.2 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -19.4% | -15.2% | 0.21 | 16.83 | -2.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -17.2% | -16.0% | 0.03 | 20.35 | -2.5 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -14.2% | -13.0% | 0.04 | 15.60 | -6.7 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -13.8% | -12.6% | 0.04 | 17.02 | -9.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -8.4% | -7.9% | 0.03 | 26.63 | -12.6 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -13.7% | -12.6% | 0.06 | 21.83 | -8.6 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -73.0% | -40.4% | 0.30 | 2.53 | -3.1 |